Apoptosis in life, death and the cell cycle

Endocrinology and Metabolism, Supplement

Volumn 3, Issue SUPPL. A, 1996, Pages 93-97

  King, Karen L ^a,b   Schwartzman, Robert A ^a,b   Cidlowski, John A ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b GEOPHYSICAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; RETINOBLASTOMA PROTEIN; RNA;

APOPTOSIS; ATROPHY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CONFERENCE PAPER; HOMEOSTASIS; LIFE; MITOSIS INHIBITION; NECROSIS; PRIORITY JOURNAL; TISSUE GROWTH;

EID: 0029548217     PISSN: 1074939X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wyllie AH. Cell death: a new classification separating apoptosis from necrosis. In: Bowen ID, Lockshin RA, editors. Cell Death in Biology and Pathology. London: Chapman and Hall, 1981: 9-34.
2. Walker NI, Harmon BV, Gobe GC, Kerr JFR. Patterns of cell death. Achiev. Exp. Pathol. 1988; 13: 18-54.
3. Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 1993; 14: 133-150.
4. Trump BF, Berezesky IK, Cowley RA. The cellular and subcellular characteristics of acute and chronic injury with emphasis on the role of calcium. In: Cowley RA, Trump BF, editors. Pathophysiology of Shock, Anoxia and Ischemia. Baltimore: Williams and Wilkins, 1982: 6-46.
5. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239-257.
6. Lockshin RA, Beaulaton J. Cell death: questions for histochemists concerning the causes of the various cytological changes. Histochem. J. 1981; 13: 659-666.
7. Stacey NH, Bishop CJ, Halliday JW, Halliday WJ, Cooksley WGE, Powell LW, Kerr JFR. Apoptosis as the mode of cell death in antibody dependent lymphocytotoxicity. J. Cell. Sci. 1985; 74: 169-179.
8. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 1993; 14: 131-136.
9. Searle J, Lawson TA, Abbott PJ, Harmon B, Kerr JFR. An electron microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol. 1975; 116: 129-138.
10. Donn MM, Ablett G, Bishop CJ, Bundesen PG, Donald KJ, Searle J, Kerr JFR. Death of cells by apoptosis following attachment of specifically allergized lymphocytes in vitro. Aust. J. Exp. Biol. 1977; 55: 407-417.
11. Compton MM, Cidlowski JA. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 1986; 118:38-45.
12. Bursch W, Taper HS, Lauer B, Schulte-Hermann R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. 1985; 50: 153-166.
13. Columbano A, Ledda-Columbano GM, Coni PP, Faa G, Liguori C, Santa Cruz G, Pan! P. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab. Invest. 1985; 52: 670-675.
14. Preston GA, Lang JE, Maronpot RR, Barrett JC. Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumor suppressor gene. Cancer Res. 1994; 54: 4214-4223.
15. King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J. Cell. Biochem. 1995; 58: 175-180.
16. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J. Cell. Biochem. 1995; 58: 160-174.
17. Murray A, Hunt T. The Cell Cycle. New York: Oxford University Press, 1993.
18. Ucker DS. Death by suicide: one way to go in mammalian cellular development. New Biol. 1991; 3: 103-109.
19. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Earnshaw WC. Nuclear events of apoptosis in vitro in cell free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 1993; 123: 7-22.
20. Murray A. Cell cycle checkpoints. Curr. Biol. 1994; 6: 872-876.
21. Nishioka WK, Welsh RM. Susceptibility of cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J. Exp. Med. 1994; 179:769-774.
22. Jones Tl, LaFrenz D. Quantitative determination of the induction of apoptosis in a murine B cell line using flow cytometric bivariate cell cycle analysis. Cell. Immunol. 1992; 142: 348-360.
23. Solary E, Bertrand R, Pommier Y. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk. Lymphoma 1994; 15: 21-32.
24. Compton MM, Haskill JS, Cidlowski JA. Analysis of glucocorticoid actions on rat thymocyte DNA by fluorescence-activated flow cytometry. Endocrinology 1988; 122: 2158-2164.
25. Freeman RS, Estus S, Johnson EM. Analysis of cell cycle related gene expression in post-mitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994; 12: 343-355.
26. Shi V, Nishioka WK, Th'ng J, Bradbury EM, Litchfield D, Greenberg AH. Premature p34 cdc2 activation required for apoptosis. Science 1994; 263: 1143-1145.
27. Meikrantz W, Gisselbrecht S, Tarn SW, Schlegel R. Activation of cyclin A dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA 1994; 91: 3754-3758.
28. Picksley SM, Lane DP. p53 and pRb: their cellular roles. Curr. Opin. Cell Biol. 1994; 6: 853-858.
29. Oren M. p53: the ultimate tumor suppressor gene? FASEB J. 1992; 6: 3169-3176.
30. Berns A. Is p53 the only real tumor suppressor gene? Curr. Biol. 1994; 4: 137-139.
31. Friend S. p53: a glimpse at the puppet behind the shadow play. Science 1994; 265: 334-335.
32. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 1992; 89:7491-7495.
33. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence J-J, May P, Oren M. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 1993; 13: 1415-1423.
34. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kiimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1993; 352: 345-347.
35. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
36. Löwe SW, Schmitt EM, Smith SW, Osbourne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
37. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
38. Haas-Kogan DA, Kogan SC, Lev! D, Dazin P, T'Ang A, Fung YKT, Israel MA. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 1995; 14: 461-472.
39. Haupt Y, Rowan S, Oren M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRb. Oncogene 1995; 10: 1563-1571.
40. Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, Hooper Ml, Berns A, te Riele H. Requirement for a functional Rb-1 gene in murine development. Nature 1992; 359: 328-330.
41. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992; 359: 295-300.
42. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992; 359: 288-294.
43. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994; 371: 72-74.